semaglutide affiliate program programs for glp 1 drugs Employer FAQs on the Rise of GLP-1 Weight Loss and the Workplace Impact Semaglutide Microdose Program | Fierce

In addition to the US FDA approved GLP-1RAs, there are GLP1/glucagon dual agonists (Cotadutide, BI 456906), GIP/GLP1 dual agonists (Tirzepatide, GIP/GLP peptide I and II), GIP/GLP1/glucagon tri-agonists (HM15211, GGG tri-agonist) and GLP1R agonists (Efpeglenatide, Rybelsus) currently in phase 1- III clinical trials for T2D, obesity, and NASH (MASH) treatments (12)

Chryssanthi DG, Dedes PG, Karamanos NK, Cordopatis P, Lamari FN (2011) Crocetin inhibits invasiveness of MDA-MB-231 breast cancer cells via downregulation of matrix metalloproteinases

The popularity of semaglutide has grown rapidly in recent years

But like all medications, side effects are possible when taking GLP-1s

GLP-1 receptor agonists like Ozempic and Wegovy were supposed to solve obesity, a genuine public health crisis affecting 42% of American adults

This matters because it narrows the gap with tirzepatide considerably